Investment Community


The healthcare delivery landscape is constantly evolving to support new products and policy reform. Understanding how and when a channel or service provider model is or should be performing is difficult as many opinions exist within industry.

Blue Fin Group supports private equity and potential acquirers assess markets, models and companies with high degrees of accuracy. We have gained a strong reputation in this community for delivering insights including audit and due diligence evaluations on potential investment opportunities on up-and-coming pharmacies with extreme objectivity. Having built businesses ourselves over our careers and working across the pharmaceutical ecosystem, we have proven to be highly adept at assessing and design business models, go-to-market strategies, and delivering highly actionable company evaluations.


Areas of Focus

analytic meeting

Private equity firms depend on Blue Fin Groups pharmaceutical and life sciences expertise to assist with investment opportunities within this field.  These investment firms also call upon Blue Fin Group experts to enhance the business model and marketing strategy of existing portfolio companies.  We work for some of the most sophisticated investment firms across the nation to enhance shareholder value.

From helping find and develop acquisition opportunities, to educating on markets to optimizing portfolio investments, Blue Fin Group’s knowledge of the pharmaceutical and life sciences sector and professional research and design methodologies ensure output that can simply not be reached through even the largest consulting firms.

For us, we value our reputation as a trusted advisor to provide open, honest and objective feedback. As we are known as a firm that tells clients what they “need to hear” as opposed to what they “want to hear” we have steered our private equity clients away from disaster and to profitable opportunities.

Blue Fin Group does not work or get paid directly by analysts but rather we provide broad market insights on trends in the market and where we think there’s opportunity with the channels and service providers in the market. Our future predictions of the markets have been on point for over 30 years and we have gained an excellent and well-guarded reputation for what will happen and why.

In turn, analysts share their views and insights on macro and micro trends that enhance our overall knowledge in the marketplace and in order for us to be better advisors and counselors to our broad set of pharmaceutical and life sciences clients.

Need Further Information?

Let our industry experts help you with the challenges and opportunities that exist in today’s healthcare landscape.

Clients Served

Getting a specialty medicine to patients is a highly complex, product-based process. We offer a comprehensive array of services that support all aspects of healthcare commerce.

medical production line

Rx Manufacturers

Manufacturers are the lifeblood of the life sciences industry. Blue Fin Group works with companies of all sizes and products at all stages, helping to achieve sustainable success via our proprietary methodology that delivers a 5-year plan for commercial excellence.

We have unparalleled industry experience in product types, therapeutic areas, navigating the healthcare ecosystem, and developing business models that can give our clients an insightful edge in today’s market.

medical industry


In healthcare, intermediaries influence the physical, financial, and transactional flows of connecting a product to a patient. Achieving excellence in this process impacts the overall success of the product.

We provide comprehensive solutions across multiple channels that offer greater transparency and more control of product flow, and greater efficiencies across the multiple stages of the supply chain. Blue Fin Group performs commercial assessments, evaluates partnerships and alliances services, and delivers directional advice on healthcare products, business models, and industry trends.

Service providers

Service Providers

Our astute knowledge of the industry as an ecosystem allows us to help service providers with many business strategy concerns, including business model design, business analytics and insights, data and technology strategy, and sales training, delivering real solutions and adding additional value to their operations.

Blue Fin Group fully understands the healthcare ecosystem, the players involved, their roles, and the relative levels of influence that each intermediary can assert. This identification can benefit clients on many levels.

financial analytics

Investment Community

For investors and financial firms interested in deeper dives in the life sciences space, Blue Fin Group assists the investment community in several key ways. With our in-depth knowledge of the life sciences landscape, we provide industry insights around current and emerging life science products, business models, and trends, as well as company evaluations, often informing M&A activity.

We can also provide insightful data and opinions on up-and-coming pharmacies and other opportunities for investment.

01 00

Latest Case Studies

View All
scientist testing

Our Customers
Love What We Do

“I really appreciated the deliberate, disciplined approach you brought to our methods and the team in general,and your calm demeanor during many of the sessions helped to keep us focused on the goal at hand. ”
Sr. Director of Pharmacy and Distribution
Top 30 Pharma Manufacturer
“Thank you Blue Fin Team for all of your support with our distribution and access strategies! We wouldn't be here without your help!”
Chief Commercial Officer
Mid-size Biotechnology Company
“I wanted to take a moment to thank you for the many years of hard work, education, partnership, support, therapy, career coaching, and friendship. I honestly could not have put this whole operation in order without you. You have been patient, kind, and at the same time strong coaches. I couldn’t have asked for better partners.”
Vice President, Channel Strategy and Patient Support Programs
“It was a pleasure to work with you to develop the distribution & channel strategy for our product. We particularly appreciated your expertise in the rare disease space, knowledge of exclusive distribution models, your thought partnership as we moved forward with tough decisions and your alignment with our patient focus. We look forward to continuing our partnership.”
Senior Strategy Manager
Pharmaceutical Manufacturer
01 00

Why Choose Blue Fin Group?

Multi Year Strategic Plans

Blue Fin Group focuses on long-range strategy, delivering a 5-year, multigenerational plan at the conclusion of each engagement. We guide you through a measured, defined process that organically adds value in a sustainable way. At the end of the five years is when we ask to be judged on the success of our advice. We are confident you will be pleased with the results.

Tailored Designs

We support your science, helping you build a commercial strategy that ensures affordable access to your product or service. You will receive a tailored business plan and related output structured for your unique situation. We carefully learn your organization’s particular needs, adjusting our methodology to best help you accomplish your business goals.

Experienced Teams

At Blue Fin Group, there are no sales people. The person who presents your business opportunity does the work to deliver it. Every team is staffed by 25, 15 and 5-years of experienced industry and consultant associates. This ensures the best mix of perspectives and knowledge while we design and optimize strategies to assist clients.

Arrange a call with our experts

    Required Field